FVSKX | VMVAX | FVSKX / VMVAX | |
Total Expense Ratio | 0.72 | 0.07 | 1,029% |
Annual Report Gross Expense Ratio | 0.72 | 0.07 | 1,029% |
Fund Existence | 17 years | 14 years | - |
Gain YTD | -9.054 | -1.683 | 538% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.67B | 29.1B | 6% |
Annual Yield % from dividends | 0.37 | 2.40 | 16% |
Returns for 1 year | -14.57 | 3.48 | -419% |
Returns for 3 years | 6.07 | 15.55 | 39% |
Returns for 5 years | 77.13 | 76.40 | 101% |
Returns for 10 years | 13.60 | 75.65 | 18% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NVD | 24.16 | 0.31 | +1.30% |
GraniteShares 2x Short NVDA Daily ETF | |||
PP | 26.10 | N/A | N/A |
Meet Kevin Pricing Power ETF (The) | |||
NOBL | 98.43 | -0.19 | -0.20% |
ProShares S&P 500 Dividend Aristocrats | |||
SEIQ | 35.00 | -0.17 | -0.47% |
SEI Enhanced US Large Cap Qual Fac ETF | |||
ARKG | 21.13 | -0.60 | -2.76% |
ARK Genomic Revolution ETF |